Table 3.
Total 1 | Bucharest | Timișoara | |
---|---|---|---|
(N = 368) (100%) | (N = 45) (100%) | (N = 323) (100%) | |
IUD retention 2 | 16 (4.34%) | 0 (0.00%) | 16 (4.95%) |
Endometrial thickening | 63 (17.11%) | 16 (35.55%) | 47 (14.55%) |
Hypertrophy | 28 (7.60%) | 3 (6.66%) | 25 (7.73%) |
Hyperplasia | 32 (8.69%) | 11 (24.44%) | 21 (6.50%) |
Neoplasia | 1 (0.27%) | 0 (0.00%) | 1 (0.30%) |
Uterine myoma | 43 (11.68%) | 6 (13.33%) | 37 (11.45%) |
Intracavitary myoma | 19 (5.16%) | 3 (6.66%) | 16 (4.95%) |
Adenomyosis | 2 (0.54%) | 2 (4.44%) | 0 (0.00%) |
Uterine septum | 3 (0.81%) | 0 (0.00%) | 3 (0.92%) |
Synechia | 34 (9.23%) | 0 (0.00%) | 34 (10.52%) |
Uterine | 26 (7.06%) | 0 (0.00%) | 26 (8.04%) |
Cervical | 8 (2.17%) | 0 (0.00%) | 8 (2.47%) |
Polyp | 186 (50.54%) | 21 (46.66%) | 165 (51.08%) |
Cervical | 16 (4.34%) | 4 (8.88%%) | 12 (3.71%) |
Endometrial | 170 (46.19%) | 17 (37.77%) | 153 (47.36%) |
Isthmocele | 1 (0.27%) | 0 (0.00%) | 1 (0.30%) |
Normal uterine cavity | 34 (9.23%) | 1 (2.22%) | 33 (10.21%) |
1 Data are presented as N (%); 2 IUD: intrauterine device.